Newtyn Management »

Vanda Pharmaceuticals shares owned by Newtyn Management

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Newtyn Management from 13F filings

Historical chart of Newtyn Management investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Newtyn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Newtyn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 290k 4.22

More positions owned by Newtyn Management

Cannae Holdings (CNNE)
Iac Com New (IAC)
PAR Technology Corporation (PAR)
G-III Apparel (GIII)
Merrimack Pharmaceuticals In Com New (MACK)
Bristow Group (VTOL)
Theravance Biopharma (TBPH)
Spectrum Brands Holding (SPB)
City Office Reit (CIO)
Allscripts Healthcare Solutions (MDRX)
Orthofix Medical (OFIX)
Bv Finl Com New (BVFL)
Apartment Invt & Mgmt Cl A (AIV)
Mitek Sys Com New (MITK)
Mbia (MBI)

View all positions for Newtyn Management

Top funds holding Vanda Pharmaceuticals

Vanguard Group
D. E. Shaw & Co
Dimensional Fund Advisors
Jacobs Levy Equity Management
Nantahala Capital Management
Millennium Management
Two Sigma Advisers
Federated Investors
Two Sigma Investments
Assenagon Asset Management
Citadel Advisors
Charles Schwab Investment Management
GSA Capital Partners
Goldman Sachs Group
Thomas Stevens, CFA"

View all funds holding Vanda Pharmaceuticals